Polycyclic compounds as lysophosphatidic acid receptor antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8778983
SERIAL NO

12893902

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AMIRA PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arruda, Jeannie M San Diego, US 35 486
Clark, Ryan San Diego, US 25 162
Seiders, Thomas Jon San Diego, US 39 493
Stearns, Brian Andrew Encinitas, US 52 580
Volkots, Deborah La Jolla, US 16 256
Zalatan, David Nathan Palo Alto, US 2 23
Zhao, Lucy San Diego, US 15 144

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 15, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00